We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$348M
AUM Growth
-$7.67M
Cap. Flow
-$4.17M
Cap. Flow %
-1.2%
Top 10 Hldgs %
74.93%
Holding
62
New
Increased
2
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$119K
2
NVTA
Invitae Corporation
NVTA
+$23.4K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.56M
2
AAPL icon
Apple
AAPL
+$1.22M
3
ADBE icon
Adobe
ADBE
+$944K
4
MSFT icon
Microsoft
MSFT
+$247K
5
ANVS icon
Annovis Bio
ANVS
+$231K

Sector Composition

Rank Sector Weight
1 Technology 39.46%
2 Healthcare 32.2%
3 Communication Services 12.12%
4 Consumer Discretionary 5.75%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
51
Abbott
ABT
$187B
$303K 0.09%
2,568
SYK icon
52
Stryker
SYK
$130B
$286K 0.08%
1,084
DIS icon
53
Walt Disney
DIS
$181B
$271K 0.08%
1,600
JPM icon
54
JPMorgan Chase
JPM
$950B
$246K 0.07%
1,500
SO icon
55
Southern Company
SO
$107B
$244K 0.07%
3,931
RIO icon
56
Rio Tinto
RIO
$164B
$227K 0.07%
3,400
LFUS icon
57
Littelfuse
LFUS
$11.6B
$219K 0.06%
800
XOM icon
58
ExxonMobil
XOM
$634B
$215K 0.06%
3,655
HRL icon
59
Hormel Foods
HRL
$13.8B
$213K 0.06%
5,195
IBM icon
60
IBM
IBM
$224B
$204K 0.06%
1,538
WU icon
61
Western Union
WU
$2.21B
$202K 0.06%
9,988
ANVS icon
62
Annovis Bio
ANVS
$80M
-2,700
Closed -$231K

Similar funds

Bourne Lent Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Bourne Lent Asset Management held 62 positions worth $348M, down 2.2% from $356M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 1.6%. Bourne Lent Asset Management opened no new positions and exited 1, leaving the 62-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

  • Bourne Lent Asset Management added most to Pacific Biosciences in Q3 2021, an estimated $119K increase.
  • Bourne Lent Asset Management's biggest Q3 2021 reduction was Idexx Laboratories, cutting an estimated $1.56M.
  • Bourne Lent Asset Management fully exited Annovis Bio in Q3 2021, selling an estimated $231K.
  • Bourne Lent Asset Management's ten largest holdings make up 75% of its $348M portfolio in Q3 2021.
  • Bourne Lent Asset Management opened 0 new positions and closed 1 in Q3 2021.
  • Bourne Lent Asset Management's portfolio value fell 2.2% quarter-over-quarter to $348M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2021, filed 20 Oct 2021.